Serum markers of lipid peroxidation, antioxidant enzymatic defense, and collagen degradation in an experimental (Pond-Nuki) canine model of osteoarthritis

被引:25
作者
Goranov, Nikolay V. [1 ]
机构
[1] Trakia Univ, Fac Med Vet, Dept Vet Surg, Stara Zagora, Bulgaria
关键词
C2C neoepitope; catalase; dog; malondialdehyde; Pond-Nuki osteoarthritis;
D O I
10.1111/j.1939-165X.2007.tb00208.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 [兽医学];
摘要
Background: Chondrocyte lipid peroxidation is strongly suggested to mediate collagen degradation and thus, to be involved in the pathogenesis of cartilage degradation and osteoarthritis (OA). Objectives: The objective of this study was to evaluate early changes in serum biochemical indicators of oxidative stress during the development of OA in a canine model. Methods: Experimental OA was induced in 7 dogs by transection of the anterior cruciate ligament (Pond-Nuki model). Venous blood samples were obtained prior to the operation and on postoperative days 30, 60, and 105. The activity of serum catalase (an antioxidant enzyme), malondialdehyde (MDA) concentration (a marker of lipid peroxidation), and serum C2C neoepitope concentration (a marker of collagen type II degradation) were measured. Results: A statistically significant increase in all parameters as early as the 30th postoperative day was observed, compared with preoperative values. Serum catalase activity peaked on day 60, whereas MDA and C2C concentrations increased continuously until the end of the experimental period. A significant positive correlation was found between MDA and C2C concentrations, but not between catalase activity and MDA or C2C concentrations. Conclusions: The results support the hypothesis that oxidative stress is involved in the pathogenesis of OA in the dog based on the Pond-Nuki model. The correlation between MDA and C2C concentrations suggests a possible association between oxidative stress and cartilage degeneration.
引用
收藏
页码:192 / 195
页数:4
相关论文
共 23 条
[1]
Biochemical markers of bone metabolism in animals: Uses and limitations [J].
Allen, MJ .
VETERINARY CLINICAL PATHOLOGY, 2003, 32 (03) :101-113
[2]
ANDREEVA LI, 1988, LAB DELO, P41
[3]
ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
[4]
Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats [J].
Campo, GM ;
Avenoso, A ;
Campo, S ;
Ferlazzo, AM ;
Altavilla, D ;
Calatroni, A .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (03) :R122-R131
[5]
Diagnostic imaging of osteoarthritis [J].
Carrig, CB .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1997, 27 (04) :777-+
[6]
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog [J].
Chu, Q ;
Lopez, M ;
Hayashi, K ;
Ionescu, M ;
Billinghurst, RC ;
Johnson, KA ;
Poole, AR ;
Markel, MD .
OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (08) :662-669
[7]
El Maadawy SS, 2003, ARTHRITIS RHEUM, V48, pS432
[8]
A SIMPLE METHOD FOR DETERMINATION OF SERUM CATALASE ACTIVITY AND REVISION OF REFERENCE RANGE [J].
GOTH, L .
CLINICA CHIMICA ACTA, 1991, 196 (2-3) :143-151
[9]
Clinical evaluation of the osteoarthritic patient [J].
Harari, J .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1997, 27 (04) :725-&
[10]
Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration [J].
Hollander, AP ;
Pidoux, I ;
Reiner, A ;
Rorabeck, C ;
Bourne, R ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2859-2869